![Michael Bauer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bauer
Direttore/Membro del Consiglio presso
DECHRA PHARMACEUTICALS
Profilo
Michael Bauer is currently Director at Dechra Pharmaceuticals Ltd., Spt Labtech Ltd., Seaport Topco Ltd., and Viturin AG.
Mr. Bauer is also Partner & Global Co-Head of Healthcare at EQT Partners AG since 2009.
Former roles include Director at VFS Global Investments AG, Director at Galderma Group AG from 2022 to 2026, and Chief Investment Officer at Capvis AG from 2003 to 2009.
Education includes an undergraduate degree from the University of St. Gallen in 2002 and an MBA from The University of Chicago Booth School of Business in 2010.
Posizioni attive di Michael Bauer
| Società | Posizione | Inizio |
|---|---|---|
| DECHRA PHARMACEUTICALS | Direttore/Membro del Consiglio | - |
EQT Partners AG
 EQT Partners AG Investment ManagersFinance Acts as an alternative investment manager | Investitore di Private Equity | 01/08/2009 |
SPT Life Sciences Group
 SPT Life Sciences Group Medical SpecialtiesHealth Technology Designs and develops automated instrumentation and consumables for life science applications | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael Bauer
| Società | Posizione | Fine |
|---|---|---|
Capvis AG
 Capvis AG Investment ManagersFinance Capvis is an active manager and invests in well-positioned midsize companies worldwide. The emphasis is on Germany, Switzerland and Austria with a focus on healthcare, industrial technology, advanced services and software. It typically targets succession situations, change of ownership, corporate spin-offs, shareholder buyouts or expansion capital. It does not invest in turnarounds. The firm generally invests EUR 15 million in companies with company values of EUR 100-500 million, aiming to identify strategic values in leading companies, take substantial equity stakes, support management to move the company to a new level of excellence and achieve an excellent return on the capital employed. It usually invests for a period of four to six years, working in consultation with management to prepare the transition to a new shareholder structure, generally achieved by IPOs or trade sales. | Direttore degli Investimenti | 09/10/2009 |
| KUONI REISEN HOLDING AG | Direttore/Membro del Consiglio | - |
Formazione di Michael Bauer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
90
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Kuoni Reisen Holding AG
 Kuoni Reisen Holding AG Other Consumer ServicesConsumer Services Operates as a travel agency | Consumer Services |
Dechra Pharmaceuticals Ltd.
 Dechra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells veterinary pharmaceuticals | Health Technology |
Capvis AG
Capvis AG Investment ManagersFinance Capvis is an active manager and invests in well-positioned midsize companies worldwide. The emphasis is on Germany, Switzerland and Austria with a focus on healthcare, industrial technology, advanced services and software. It typically targets succession situations, change of ownership, corporate spin-offs, shareholder buyouts or expansion capital. It does not invest in turnarounds. The firm generally invests EUR 15 million in companies with company values of EUR 100-500 million, aiming to identify strategic values in leading companies, take substantial equity stakes, support management to move the company to a new level of excellence and achieve an excellent return on the capital employed. It usually invests for a period of four to six years, working in consultation with management to prepare the transition to a new shareholder structure, generally achieved by IPOs or trade sales. | Finance |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SPT Life Sciences Group
SPT Life Sciences Group Medical SpecialtiesHealth Technology Designs and develops automated instrumentation and consumables for life science applications | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EQT Partners AG
EQT Partners AG Investment ManagersFinance Acts as an alternative investment manager | Finance |
